The organization known as Veterans Prostate Cancer Awareness (VPCa) was initially founded by Mike (“Bing”) Crosby back in 2016. … READ MORE …
Filed under: Uncategorized | Tagged: awareness, veteran, VPCa | Leave a comment »
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
-
PCaI’s ASVSG
If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.
CureTalks on PCa
Our most recent CureTalk on Prostate Cancer (on February 21 this year) features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.
For access to the full list of CureTalks on Prostate Cancer, please click here.
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- New trial (S1802) for treatment of men with newly diagnosed, metastatic prostate cancer
- But annual, mass, population-based PSA screening really works (or does it?)
- Hypothetical cost savings associated with “observation” for low-risk prostate cancer
- What prostate cancer awareness means to Dr. Alicia Morgans
- “Prostate Cancer Today” — Dr. Frans Debruyne joins meeting faculty
- ASCO endorses AUA/ASTRO/SUO guidelines on treatment of localized prostate cancer
- Gallium-68 PET/CT scans prior to first-line treatment of some men with prostate cancer
- Updated results of 5-year SBRT trial: high cancer control, low toxicity
- Liver disease as an adverse event for men on ADT
- It’s Prostate Cancer Awareness Month, again …
- Continuity of care for men initially started on active surveillance
- Advances in the identification of patients who may respond well to particular types of immunotherapy
- The androgen-sensitive to androgen-resistant transition: an hypothesis
- Does local treatment at time of diagnosis improve outcomes for men initially diagnosed with metastatic disease?
- Free randomized clinical trial of gallium-68-PSMA-11 PET indicator
… and Archives
Blog at WordPress.com. WP Designer.
